Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | 18:2 | cPLA2i | 1.0 | BCD110605C28 | 101 | pmol/ml of cells |
| - | 18:2 | cPLA2i | 1.0 | BCD110605C30 | 94.1 | pmol/ml of cells |
| - | 18:2 | cPLA2i | 1.0 | BCD110605C29 | 96.5 | pmol/ml of cells |
| - | 18:2 | cPLA2i | 20.0 | BCD110605C64 | 70.4 | pmol/ml of cells |
| - | 18:2 | cPLA2i | 20.0 | BCD110605C66 | 71.5 | pmol/ml of cells |
| - | 18:2 | cPLA2i | 20.0 | BCD110605C65 | 60.1 | pmol/ml of cells |
| - | 18:2 | PLDi | 1.0 | BCD110605C16 | 69.9 | pmol/ml of cells |
| - | 18:2 | PLDi | 1.0 | BCD110605C17 | 89.3 | pmol/ml of cells |
| - | 18:2 | PLDi | 1.0 | BCD110605C18 | 72.8 | pmol/ml of cells |
| - | 18:2 | PLDi | 20.0 | BCD110605C54 | 49.5 | pmol/ml of cells |
| - | 18:2 | PLDi | 20.0 | BCD110605C52 | 59.5 | pmol/ml of cells |
| - | 18:2 | PLDi | 20.0 | BCD110605C53 | 63 | pmol/ml of cells |
| - | 18:2 | KDO+cPLA2i | 1.0 | BCD110605C32 | 109 | pmol/ml of cells |
| - | 18:2 | KDO+cPLA2i | 1.0 | BCD110605C31 | 112 | pmol/ml of cells |
| - | 18:2 | KDO+cPLA2i | 1.0 | BCD110605C33 | 91.8 | pmol/ml of cells |
| - | 18:2 | KDO+cPLA2i | 20.0 | BCD110605C68 | 93.5 | pmol/ml of cells |
| - | 18:2 | KDO+cPLA2i | 20.0 | BCD110605C69 | 81.2 | pmol/ml of cells |
| - | 18:2 | KDO+cPLA2i | 20.0 | BCD110605C67 | 96 | pmol/ml of cells |
| - | 18:2 | KDO+PLDi | 1.0 | BCD110605C19 | 89.6 | pmol/ml of cells |
| - | 18:2 | KDO+PLDi | 1.0 | BCD110605C20 | 77.8 | pmol/ml of cells |
| - | 18:2 | KDO+PLDi | 1.0 | BCD110605C21 | 86.1 | pmol/ml of cells |
| - | 18:2 | KDO+PLDi | 20.0 | BCD110605C56 | 80.9 | pmol/ml of cells |
| - | 18:2 | KDO+PLDi | 20.0 | BCD110605C57 | 80.2 | pmol/ml of cells |
| - | 18:2 | KDO+PLDi | 20.0 | BCD110605C55 | 86.8 | pmol/ml of cells |
| - | 18:2 | KDO+ATP+cPLA2i | 1.0 | BCD110605C37 | 132 | pmol/ml of cells |
| - | 18:2 | KDO+ATP+cPLA2i | 1.0 | BCD110605C38 | 83 | pmol/ml of cells |
| - | 18:2 | KDO+ATP+cPLA2i | 1.0 | BCD110605C39 | 80.5 | pmol/ml of cells |
| - | 18:2 | KDO+ATP+cPLA2i | 20.0 | BCD110605C74 | 100 | pmol/ml of cells |
| - | 18:2 | KDO+ATP+cPLA2i | 20.0 | BCD110605C75 | 101 | pmol/ml of cells |
| - | 18:2 | KDO+ATP+cPLA2i | 20.0 | BCD110605C73 | 110 | pmol/ml of cells |
| - | 18:2 | KDO+ATP+PLDi | 1.0 | BCD110605C25 | 88.9 | pmol/ml of cells |
| - | 18:2 | KDO+ATP+PLDi | 1.0 | BCD110605C27 | 112 | pmol/ml of cells |
| - | 18:2 | KDO+ATP+PLDi | 1.0 | BCD110605C26 | 90.5 | pmol/ml of cells |
| - | 18:2 | KDO+ATP+PLDi | 20.0 | BCD110605C61 | 99.8 | pmol/ml of cells |
| - | 18:2 | KDO+ATP+PLDi | 20.0 | BCD110605C62 | 78.5 | pmol/ml of cells |
| - | 18:2 | KDO+ATP+PLDi | 20.0 | BCD110605C63 | 69.3 | pmol/ml of cells |
| - | 18:2 | KDO + ATP | 1.0 | BCD110605C15 | 48.5 | pmol/ml of cells |
| - | 18:2 | KDO + ATP | 1.0 | BCD110605C14 | 44.6 | pmol/ml of cells |
| - | 18:2 | KDO + ATP | 1.0 | BCD110605C13 | 54.6 | pmol/ml of cells |
| - | 18:2 | KDO + ATP | 20.0 | BCD110605C49 | 100 | pmol/ml of cells |
| - | 18:2 | KDO + ATP | 20.0 | BCD110605C50 | 131 | pmol/ml of cells |
| - | 18:2 | KDO + ATP | 20.0 | BCD110605C51 | 134 | pmol/ml of cells |
| - | 18:2 | KDO | 1.0 | BCD110605C08 | 44.6 | pmol/ml of cells |
| - | 18:2 | KDO | 1.0 | BCD110605C07 | 54.6 | pmol/ml of cells |
| - | 18:2 | KDO | 1.0 | BCD110605C09 | 48.5 | pmol/ml of cells |
| - | 18:2 | KDO | 20.0 | BCD110605C45 | 82.6 | pmol/ml of cells |
| - | 18:2 | KDO | 20.0 | BCD110605C44 | 101 | pmol/ml of cells |
| - | 18:2 | KDO | 20.0 | BCD110605C43 | 135 | pmol/ml of cells |
| - | 18:2 | C | 0.0 | BCD110605C03 | 104 | pmol/ml of cells |
| - | 18:2 | C | 0.0 | BCD110605C01 | 106 | pmol/ml of cells |